@article{21556,
  keywords = {Child, Drug Therapy, Combination, Female, Humans, Leprostatic Agents, Leprosy, Borderline, Skin},
  author = {Di Martino Ortiz B and Masi MR and Knopfelmacher O and Lezcano LB},
  title = {[Childhood leprosy: Report of a case].},
  abstract = {<p>Childhood leprosy is very common, especially in tropical and subtropical areas, such as Paraguay. Early symptoms can be missed in a routine examination and the diagnosis can pass unnoticed. Pediatricians and dermatologists should remember the manifestations of this disease in order to make an early diagnosis. We present the case of a 10-year-old child with borderline Hansen disease, considered unusual in children. She was treated with multibacillary therapy (MB-WHO) with the combination of Rifampicin 600 mg, clofazimine 300 mg, and dapsone 100 mg once a month (the three drugs together on the same day once a month for 18 months); the remaining 28 days of the month, the child received clofazimine 50 mg/day and dapsone 100 mg/day (the two drugs together on the same day 28 days of the month for 18 months). This therapy produced complete remission of the lesions without reactional states.</p>},
  year = {2011},
  journal = {Dermatology online journal},
  volume = {17},
  pages = {13},
  month = {2011 Jan 15},
  issn = {1087-2108},
  url = {http://dermatology.cdlib.org/1701/8_vignette/13_10-00171/ortiz.html},
  language = {spa},
}